申请人:Fujisawa Pharmaceutical Co., Ltd.
公开号:US04563453A1
公开(公告)日:1986-01-07
New thiazine derivatives of the formula: ##STR1## wherein R.sup.1 is hydrogen or acyl, R.sup.2 is hydrogen or lower alkyl, R.sup.3 is hydrogen, hydroxy, halogen, lower alkyl or lower alkoxy, Z is taken together with the adjacent carbon atoms to form an unsaturated heterocyclic ring which may be substituted with phenyl, halogen, acyl or lower alkyl, and the heavy solid line means single or double bond, and pharmaceutically acceptable salts thereof, and processes for preparation thereof and pharmaceutical composition comprising the same. These derivatives and salts thereof are useful as antiinflammatory, analgesic and antirheumatic agents.
新的噻嗪衍生物的化学式为:其中R.sup.1为氢或酰基,R.sup.2为氢或较低的烷基,R.sup.3为氢、羟基、卤素、较低的烷基或较低的烷氧基,Z与相邻的碳原子一起形成一个不饱和的杂环环,该环可能被苯基、卤素、酰基或较低的烷基取代,粗实线表示单键或双键,以及其药用可接受的盐,以及其制备方法和包含相同的药物组合物。这些衍生物及其盐可作为抗炎、镇痛和抗风湿药物。